All stock lists
Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
Healthcare · Biotechnology
$2.15-$0.63 (-22.66%)
Insider Score
34/ 100
UPB Insider Score
Bearish0 qualifying trades · 0 insiders · $0 bought in the last 90 days
UPB Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $395.00 K | $773.00 K | $1.03 M | $668.00 K | $683.00 K |
| Revenue Growth (YoY) | -42.17 % | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | $7.17 M | $7.05 M | $8.08 M | $6.67 M | $5.54 M |
| R&D Expense | $36.61 M | $36.09 M | $36.56 M | $40.17 M | $32.98 M |
| Operating Expenses | $43.77 M | $43.14 M | $44.65 M | $46.84 M | $38.52 M |
| Operating Income | -$43.38 M | -$42.37 M | -$43.62 M | -$46.17 M | -$37.83 M |
| Pretax Income | -$41.19 M | -$39.70 M | -$40.59 M | -$42.46 M | -$33.75 M |
| Tax Provision | — | — | — | — | — |
| Net Income | -$41.19 M | -$39.70 M | -$40.59 M | -$42.46 M | -$33.75 M |
| EPS (Basic) | -$0.75 | -$0.73 | -$0.75 | -$0.78 | -$0.63 |
| EPS (Diluted) | -$0.75 | -$0.73 | -$0.75 | -$0.78 | -$0.63 |
| Shares Outstanding | 54.78 M | 54.57 M | 54.33 M | 54.24 M | 53.93 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
